TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization
Go back to TriSalus Life Sciences Receives FDA Clearance for TriNav® Advance, Strengthening Comprehensive Pressure-Enabled Drug Delivery™ (PEDD™) Portfolio for Liver Embolization| (NASDAQ: TLSI) | Delayed: 3.67 +0.01 (0.27%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $3.66 | 52 Week High | $ | |||
| Open | $3.68 | 52 Week Low | $ | |||
| Day High | $3.72 | P/E | N/A | |||
| Day Low | $3.60 | EPS | $ | |||
| Volume | 14,238 | |||||



